148 related articles for article (PubMed ID: 16118700)
21. Screening technologies for G protein-coupled receptors: from HTS to uHTS.
De los Frailes M; Diez E
Methods Mol Biol; 2009; 552():15-37. PubMed ID: 19513639
[TBL] [Abstract][Full Text] [Related]
22. The 7 TM G-protein-coupled receptor target family.
Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
[TBL] [Abstract][Full Text] [Related]
23. Molecular profiling of murine sensory neurons in the nodose and dorsal root ganglia labeled from the peritoneal cavity.
Peeters PJ; Aerssens J; de Hoogt R; Stanisz A; Göhlmann HW; Hillsley K; Meulemans A; Grundy D; Stead RH; Coulie B
Physiol Genomics; 2006 Feb; 24(3):252-63. PubMed ID: 16303873
[TBL] [Abstract][Full Text] [Related]
24. APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology.
Adams JW; Ramirez J; Shi Y; Thomsen W; Frazer J; Morgan M; Edwards JE; Chen W; Teegarden BR; Xiong Y; Al-Shamma H; Behan DP; Connolly DT
J Pharmacol Exp Ther; 2009 Oct; 331(1):96-103. PubMed ID: 19628629
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain.
Cristino L; de Petrocellis L; Pryce G; Baker D; Guglielmotti V; Di Marzo V
Neuroscience; 2006; 139(4):1405-15. PubMed ID: 16603318
[TBL] [Abstract][Full Text] [Related]
26. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
27. Abstracts of the joint meeting of the Swiss Society of Pharmacology and Toxicology, the German Society for Experimental and Clinical Pharmacology and Toxicology, the Austrian Pharmacological Society. 1-2 October 20001, Berne, Switzerland.
Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3 Suppl):R1-33. PubMed ID: 11592278
[No Abstract] [Full Text] [Related]
28. Glutamate- and GABA-based CNS therapeutics.
Foster AC; Kemp JA
Curr Opin Pharmacol; 2006 Feb; 6(1):7-17. PubMed ID: 16377242
[TBL] [Abstract][Full Text] [Related]
29. Comparative physiology, pharmacology and toxicology of beta-blockers: mammals versus fish.
Owen SF; Giltrow E; Huggett DB; Hutchinson TH; Saye J; Winter MJ; Sumpter JP
Aquat Toxicol; 2007 May; 82(3):145-62. PubMed ID: 17382413
[TBL] [Abstract][Full Text] [Related]
30. [Opening address of the 23rd meeting of the German Pharmacological Society].
HOLTZ P
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1957; 232(1):1-11. PubMed ID: 13526820
[No Abstract] [Full Text] [Related]
31. British Pharmacological Society, 5th Focused Meeting on Cell Signalling: Matters arising ….
Willars GB; Tobin AB; Challiss RA
Br J Pharmacol; 2015 Jul; 172(13):3194-5. PubMed ID: 26095874
[No Abstract] [Full Text] [Related]
32. The Polish Pharmacological Society. Symposium on pharmacological regulation of the mechanisms in the central nervous system. Joint meeting with the Pharmacological Society of German Democratic Republic. Ustroń-Jaszowiec, November 5-8, 1984.
Pol J Pharmacol Pharm; 1985; 37(6):727-918. PubMed ID: 3832016
[No Abstract] [Full Text] [Related]
33. British Fertility Society Workshop British Andrology Society Annual Meeting Association of Clinical Embryologists Workshop University of Birmingham 13 and 14 November 1998.
Hum Fertil (Camb); 1999 May; 2(1):75-83. PubMed ID: 16087515
[No Abstract] [Full Text] [Related]
34. Proceedings of the British Pharmacological Society Meeting. Nottingham, 14-16 July 1999.
Br J Pharmacol; 1999 Oct; 128 Suppl(Suppl):1P-224P. PubMed ID: 10589328
[No Abstract] [Full Text] [Related]
35. British Pharmacology Society Winter Meeting: focus on neuropharmacology.
Burroughs S; Lethbridge N; Chazot PL
Expert Rev Clin Pharmacol; 2009 Mar; 2(2):163-7. PubMed ID: 24410647
[TBL] [Abstract][Full Text] [Related]
36. Italian Pharmacological Society, 1st inter-regional meeting. Pavia, October 5, 1987. Pharmacology of neurotransmission. Reviews and communications.
Pharmacol Res Commun; 1987 Dec; 19(12):925-80. PubMed ID: 2896365
[No Abstract] [Full Text] [Related]
37. British Pharmacology Society - Autumn Meeting 2002.
Lawson K
IDrugs; 2002 Oct; 5(10):969-71. PubMed ID: 14689938
[No Abstract] [Full Text] [Related]
38. British Fertility Society and Association of Clinical Embryologists Joint Winter Meeting Bath 11-12 January 2000.
Hum Fertil (Camb); 2000 May; 3(2):129-151. PubMed ID: 16087521
[No Abstract] [Full Text] [Related]
39. THE MODERN TREATMENT OF FUNCTIONAL NERVOUS DISORDERS: A British Medical Association Lecture delivered to a Joint Meeting of the Nottingham Division and the Nottingham Medico-Chirurgical Society, January 7th, 1920.
Hart B
Br Med J; 1920 Feb; 1(3085):207-11. PubMed ID: 20769787
[No Abstract] [Full Text] [Related]
40. Proceeding of the British Pharmacological Society meeting. 22-24, April 1998.
Br J Pharmacol; 1998 Jul; 124 Suppl(Suppl):1P-153P. PubMed ID: 9806074
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
